HFA Premium Access

Real world data comparing HF guideline directed medical therapy before and after 2021 ESC HF guidelines.

Congress Presentation

About the speaker

Mr Marco Ferrari

University of Brescia, Brescia (Italy)
0 follower

7 more presentations in this session

Benefits of empagliflozin in Hispanics and non-Hispanics with heart failure: a sub-analysis of the EMPEROR-trials

Speaker: Doctor M. Gamero (Philadelphia, US)


Prognostic impact of pharmacotherapy optimisation status in HFrEF patients using a contemporary measurement score

Speaker: Doctor A. Jordan (Mexico City, MX)


Beta-blockers and antiplatelet therapy in Takotsubo syndrome - To do or not to do?

Speaker: Doctor P. Rocha Carvalho (Vila Real, PT)


Persistence to guideline-based therapy newly prescribed after a hospitalization for heart failure. Data from two large cohorts in the US and Germany.

Speaker: Doctor A. Michel (Basel, CH)


Hydrochlorothiazide for the treatment of acute volume overload worsening heart failure

Speaker: Associate Professor R. Rascon Sabido (Veracruz, MX)


Access the full session

Chronic heart failure - pharmacotherapy 3

Speakers: Mr M. Ferrari, Doctor M. Gamero, Doctor A. Jordan, Doctor P. Rocha Carvalho, Doctor A. Michel...

About the event


Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by